Key U.S. Health Industries Outline Six-Point Plan for Improved Health and Economic Growth in Asia-Pacific Region
Honolulu – Leaders from several U.S. health care industries today endorsed a six-point “Action Plan” for how economies in the Asia-Pacific Economic Cooperation forum (APEC) can help jump start economic growth by making better health a priority and they called on government leaders to commit to the plan.
Fostering Access to Innovative Medicines in Indonesia
Washington, D.C. (December 6, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today in response to the September 3, 2012 Indonesian Presidential Decree (76/2012) that grants compulsory licenses on nine innovative biopharmaceutical products:
Innovative Medicines Help Turn HIV Infection into Chronic Disease
Washington, D.C. (November 29, 2012) — America’s biopharmaceutical research companies are currently developing 73 innovative medicines and vaccines to help the nearly 1.2 million Americans living with HIV infection today, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) released today.
Innovation & Adherence: Two Paths to Better Controlling Diabetes
Washington, D.C. (November 13, 2012) — America’s biopharmaceutical research companies currently are developing 221 innovative new medicines to help the nearly 26 million patients in the United States affected by diabetes.